Related Experiment Videos
Novel mutations in the CHST6 gene causing macular corneal dystrophy
C Abbruzzese1, U Kuhn, F Molina
1Laboratory of Tissue Engineering I.D.I., Istituto Dermopatico dell' Immacolata, Rome, Italy.
Clinical Genetics
|February 27, 2004
Summary
Genetic defects in the CHST6 gene cause Macular Corneal Dystrophy (MCD). This study identified novel mutations and deletions in Italian families, furthering understanding of MCD types I and II.
Area of Science:
- Ophthalmology
- Genetics
- Biochemistry
Background:
- Macular Corneal Dystrophy (MCD) is an inherited eye condition causing corneal clouding.
- It results from mutations in the CHST6 gene, affecting carbohydrate sulfotransferase activity.
- MCD presents as Type I (missense mutations) or Type II (upstream deletions/rearrangements).
Purpose of the Study:
- To identify the specific genetic mutations causing Macular Corneal Dystrophy in Italian families.
- To correlate identified genetic defects with MCD clinical phenotypes (Type I and Type II).
Main Methods:
- Genotyping using polymerase chain reaction (PCR) and direct sequencing of the CHST6 gene.
- Confirmation of mutations via restriction analysis.
- Enzyme-linked immunosorbent assay (ELISA) to detect serum sulfated keratan sulfate levels.
Main Results:
- Two Italian families exhibited a Macular Corneal Dystrophy Type I phenotype.
- Two novel missense mutations and one polymorphism in the CHST6 coding region were found in MCD Type I patients.
- One MCD Type II family presented with a homozygous deletion in the upstream region of the CHST6 gene.
Conclusions:
- Novel CHST6 mutations and deletions are associated with Macular Corneal Dystrophy in Italian populations.
- These findings expand the spectrum of known genetic defects causing MCD.
- Genetic identification aids in understanding disease mechanisms and potential future diagnostics.